Rafael Rivas‐Chacon

1.0k total citations
8 papers, 483 citations indexed

About

Rafael Rivas‐Chacon is a scholar working on Rheumatology, Hematology and Molecular Biology. According to data from OpenAlex, Rafael Rivas‐Chacon has authored 8 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 3 papers in Hematology and 2 papers in Molecular Biology. Recurrent topics in Rafael Rivas‐Chacon's work include Autoimmune and Inflammatory Disorders Research (3 papers), Eosinophilic Disorders and Syndromes (2 papers) and Inflammatory Myopathies and Dermatomyositis (2 papers). Rafael Rivas‐Chacon is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (3 papers), Eosinophilic Disorders and Syndromes (2 papers) and Inflammatory Myopathies and Dermatomyositis (2 papers). Rafael Rivas‐Chacon collaborates with scholars based in United States and Canada. Rafael Rivas‐Chacon's co-authors include Lauren M. Pachman, Barry L. Myones, Saul M. Schanberg, Tiffany Field, Maria Hernandez‐Reif, Cynthia M. Kuhn, Gail Cawkwell, Alan R. Dyer, Rebecca B. Lipton and Christine Hom and has published in prestigious journals such as The Journal of Pediatrics, Journal of Pediatric Psychology and JCI Insight.

In The Last Decade

Rafael Rivas‐Chacon

8 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rafael Rivas‐Chacon United States 8 212 182 106 103 100 8 483
Rik Joos Belgium 15 53 0.3× 392 2.2× 221 2.1× 139 1.3× 93 0.9× 29 608
M Okuni Japan 14 51 0.2× 90 0.5× 128 1.2× 31 0.3× 81 0.8× 61 616
F. Bracci Italy 14 133 0.6× 23 0.1× 24 0.2× 51 0.5× 72 0.7× 35 537
Stéphane Debeugny France 8 148 0.7× 59 0.3× 23 0.2× 77 0.7× 59 0.6× 18 537
Orla Killeen Ireland 9 29 0.1× 62 0.3× 66 0.6× 59 0.6× 45 0.5× 26 263
Hanna Säilä Finland 10 14 0.1× 59 0.3× 103 1.0× 79 0.8× 48 0.5× 21 313
Erminia Romeo Italy 17 178 0.8× 36 0.2× 28 0.3× 41 0.4× 91 0.9× 32 830
Karima Benbouazza Morocco 11 23 0.1× 197 1.1× 82 0.8× 62 0.6× 9 0.1× 37 382
MW Lin Taiwan 5 99 0.5× 53 0.3× 12 0.1× 110 1.1× 25 0.3× 7 411
J. L. Kalliomäki Finland 13 99 0.5× 168 0.9× 57 0.5× 64 0.6× 34 0.3× 63 503

Countries citing papers authored by Rafael Rivas‐Chacon

Since Specialization
Citations

This map shows the geographic impact of Rafael Rivas‐Chacon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael Rivas‐Chacon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael Rivas‐Chacon more than expected).

Fields of papers citing papers by Rafael Rivas‐Chacon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael Rivas‐Chacon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael Rivas‐Chacon. The network helps show where Rafael Rivas‐Chacon may publish in the future.

Co-authorship network of co-authors of Rafael Rivas‐Chacon

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael Rivas‐Chacon. A scholar is included among the top collaborators of Rafael Rivas‐Chacon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael Rivas‐Chacon. Rafael Rivas‐Chacon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Jesus, Adriana A. de, Dawn Chapelle, Paul Dancey, et al.. (2017). Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist. JCI Insight. 2(16). 35 indexed citations
2.
Aksentijevich, Ivona, et al.. (2012). Deficiency of Interleukin‐1 Receptor Antagonist Responsive to Anakinra. Pediatric Dermatology. 30(6). 758–760. 48 indexed citations
3.
Gabay, Michael, et al.. (2011). Evidence of Acute Mycoplasma Infection in a Patient with Incomplete and Atypical Kawasaki Disease: A Case Report. Case Reports in Medicine. 2011. 1–4. 11 indexed citations
4.
Bout‐Tabaku, Sharon, Rafael Rivas‐Chacon, & Ricardo Restrepo. (2007). Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.. PubMed. 34(12). 2503–4. 16 indexed citations
5.
Pachman, Lauren M., Kathy Abbott, James Sinacore, et al.. (2006). Duration of illness is an important variable for untreated children with juvenile dermatomyositis. The Journal of Pediatrics. 148(2). 247–253. 94 indexed citations
6.
Pachman, Lauren M., Rebecca B. Lipton, Rosalind Ramsey‐Goldman, et al.. (2005). History of infection before the onset of juvenile dermatomyositis: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Care & Research. 53(2). 166–172. 104 indexed citations
7.
Field, Tiffany, et al.. (1997). Juvenile Rheumatoid Arthritis: Benefits from Massage Theraphy. Journal of Pediatric Psychology. 22(5). 607–617. 103 indexed citations
8.
Myones, Barry L., et al.. (1992). Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. The Journal of Pediatrics. 120(3). 468–473. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026